CSX NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

CSX Corporation · Industrials · Railroads

Open interactive chart View report data Download investor PDF
Latest close 53.23 USD
4.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 23.7% above the Trend Line and sits at 99.2% of its 52-week range. The latest completed week returned 4.9%, after a 11.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 54/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high; earnings are due in 84d.

Setup score 83 out of 100
Latest Close 53.23 USD 24 Jul 2026
1W Return 4.9% latest completed week
4W Return 11.7% short-term follow-through
12W Return 18.4% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 54-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.9% Latest completed week; four-week move 11.7%. Indicator stack 100/81 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.01% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 54/100 conviction; expected move 3.8%. News sentiment 56/100 11 relevant articles in the latest sentiment read. Event risk 84d Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 23.7% above the Trend Line and sits at 99.2% of its 52-week range. The latest completed week returned 4.9%, after a 11.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9912-week average 0.94

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.99Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.7% over four weeks, 18.4% over 12 weeks, and 51.0% over one year. The current trend has remained active for 54 consecutive weeks.

Performance by holding period

1W4.9%
4W11.7%
12W18.4%
26W46.2%
52W51.0%
Active trend streak54 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.67Latest activity-pressure read.
Pressure change13.0%Four-week change in activity pressure.
Leadership24.14Latest relative-leadership reading.
RS change165.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality88/100Profitability and accounting quality. Underlying universe rank 13; rank 1 is best.
Momentum84/100Medium-term price momentum. Underlying universe rank 17; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework31/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.6x
Price divided by trailing earnings.
Price / sales
6.8x
Market value relative to trailing revenue.
EV / EBITDA
17.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.9%
Gross profit retained from each unit of revenue.
Operating margin
34.8%
Operating profit retained from revenue.
Free-cash-flow margin
59.4%
Free cash flow generated from revenue.
Return on invested capital
11.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.5%
Latest one-year revenue growth.
EPS growth
3.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
8.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.0%
Cash dividends relative to market value.
Buyback yield
0.8%
Net share repurchases relative to market value.
Shareholder yield
1.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

CSX shows bullish options pressure with a 54/100 conviction score, put-call volume ratio of 0.04, expected move of 3.8%, and Sharemaestro trend signal active.

Conviction54/100
Expected move3.8%
Put/call volume0.04
Pressure94
Speculation43
Volatility29
Trend agreement8
Open options detail
Insider activity7 / 4

7 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 11 relevant articles.

3 positive · 8 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
Options expected move3.8%Nearest-chain priced movement where available.
52-week drawdown-0.3%Distance below the 52-week high.
13-week volatility2.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+7.5%Week of 6 Feb.
Worst week-6.4%Week of 6 Mar.
Latest week+4.9%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains14
Flat weeks0
Modest losses6
Sharp losses2
Recent vol2.4%13-week weekly-return volatility.
Base vol2.9%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape84/100

Trend, activity pressure, participation, and risk combine to a 84/100 tape read.

 Indicator analysis84/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.

Activity pressure 0.99; 3 reversal markers Next-Week ExpectancyPositive 55.01%

Next-week expectancy is positive with a 55.01% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 33 SVQF31/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 498.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options50/100

CSX shows bullish options pressure with a 54/100 conviction score, put-call volume ratio of 0.04, expected move of 3.8%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 3.8% Sentiment56/100

Weighted news tone is neutral across 11 relevant articles.

Weekly Recap: CSX Corporation Q2 earnings growth and analyst target hikes Insiders7 / 4

7 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings84d

Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202653.23 USD4.9%43.02 USD34.62 USD1.6724.1486.5MOn
17 Jul 202650.75 USD2.7%42.46 USD34.49 USD1.6317.0161.7MOn
10 Jul 202649.41 USD1.1%41.98 USD34.36 USD1.509.6048.5MOn
3 Jul 202648.89 USD2.6%41.57 USD34.25 USD1.5210.6648.1MOn
26 Jun 202647.66 USD4.4%41.14 USD34.14 USD1.489.1065.0MOn
19 Jun 202645.63 USD-4.1%40.73 USD34.05 USD1.260.0160.8MOn
12 Jun 202647.57 USD1.2%40.34 USD33.95 USD1.167.0951.2MOn
5 Jun 202646.99 USD3.8%39.90 USD33.85 USD1.168.4263.1MOn
29 May 202645.26 USD-0.3%39.50 USD33.75 USD1.10-0.0765.0MOn
22 May 202645.38 USD-0.3%39.18 USD33.66 USD1.113.1252.4MOn
15 May 202645.52 USD1.9%38.86 USD33.55 USD1.334.8274.3MOn
8 May 202644.69 USD-0.6%38.55 USD33.46 USD1.132.7455.9MOn
1 May 202644.95 USD-0.7%38.23 USD33.37 USD0.999.1851.0MOn
24 Apr 202645.27 USD4.8%37.92 USD33.28 USD0.8811.9779.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.